TREATMENT OF SYSTEMIC MYCOSES WITH KETOCONAZOLE - INVITRO SUSCEPTIBILITIES OF CLINICAL ISOLATES OF SYSTEMIC AND PATHOGENIC FUNGI TO KETOCONAZOLE

被引：46

作者：

SHADOMY, S ^{[1
]}

WHITE, SC ^{[1
]}

YU, HP ^{[1
]}

DISMUKES, WE ^{[1
]}

机构：

[1] UNIV ALABAMA,SCH MED,DEPT MED,DIV INFECT DIS,BIRMINGHAM,AL 35233

来源：

JOURNAL OF INFECTIOUS DISEASES | 1985年 / 152卷 / 06期

关键词：

D O I：

10.1093/infdis/152.6.1249

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：1249 / 1256

页数：8

相关论文

共 12 条

[1] [Anonymous], 1980, MANUAL CLIN MICROBIO
[2] BRASS C, 1980, REV INFECT DIS, V2, P656
[3] CYTOCHEMICAL AND BIOCHEMICAL STUDIES OF YEASTS AFTER INVITRO EXPOSURE TO MICONAZOLE
DENOLLIN, S
VANBELLE, H
GOOSSENS, F
THONE, F
BORGERS, M
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (03) : 500 - 513
[4] TREATMENT OF SYSTEMIC MYCOSES WITH KETOCONAZOLE - EMPHASIS ON TOXICITY AND CLINICAL-RESPONSE IN 52 PATIENTS
DISMUKES, WE
STAMM, AM
GRAYBILL, JR
CRAVEN, PC
STEVENS, DA
STILLER, RL
SAROSI, GA
MEDOFF, G
GREGG, CR
GALLIS, HA
FIELDS, BT
MARIER, RL
KERKERING, TA
KAPLOWITZ, LG
CLOUD, G
BOWLES, C
SHADOMY, S
[J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) : 13 - 20
[5] COMPARISON OF INVITRO ANTIFUNGAL ACTIVITIES OF MICONAZOLE AND A NEW IMIDAZOLE, R41,400
DIXON, D
SHADOMY, S
SHADOMY, HJ
ESPINELINGROFF, A
KERKERING, TM
[J]. JOURNAL OF INFECTIOUS DISEASES, 1978, 138 (02) : 245 - 248
[6] ESPINELINGROFF A, 1981, 21ST INT C ANT AG CH
[7] GRAYBILL JR, 1980, REV INFECT DIS, V2, P661
[8] Grove D.C., 1955, ASSAY METHODS ANTIBI
[9] HEEL RC, 1982, KETOCONAZOLE MANAGEM, P57
[10] RYLEY JF, 1984, SABOURAUDIA, V22, P53